The efficacy of venlafaxine in the treatment of depression, withdrawal symptoms, and craving in individuals with methamphetamine dependence

References

• Althobaiti, Y.S. (2019). Role of venlafaxine in relapse to methamphetamine seeking. Potential treatment option for drug dependence. Saudi Medical Journal, 40(4), 339–346. https://doi.org/10.15537/smj.2019.4.23718
   PubMed Web of Science ®Google Scholar
• Baker, A., Lee, N.K., Claire, M., Lewin, T. J., Grant, T., Pohlman, S., Saunders, J. B., Kay Lambkin, F., Constable, P., Jenner, L., & Carr, V. J. (2005). Brief cognitive-behavioral interventions for regular amphetamine users: A step in the right direction. Addiction, 100(3), 367–378. https://doi.org/10.1111/j.1360-0443.2005.01002.x
   PubMed Web of Science ®Google Scholar
• Beck, A. T., Steer, R. A., & Brown, G. K. (2000). Manual for the beck depression inventory ـ II. the psychological corporation.
   Google Scholar
• Breese, G.R., Sinha, R., & Heilig, M. (2011). Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse. Pharmacology & Therapeutics, 129(2), 149–171. https://doi.org/10.1016/j.pharmthera.2010.09.007
   PubMed Web of Science ®Google Scholar
• Bymaster, F.P., Dreshfield-Ahmad, L.J., Threlkeld, P.G., Shaw, J.L., Thompson, L., Nelson, D.L., Hemrick-Luecke, S.K., & Wong, D.T. (2001). Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacology, 25(6), 871–880. https://doi.org/10.1016/S0893-133X(01)00298-6
   PubMed Web of Science ®Google Scholar
• Cipriani, A., Koesters, M., Furukawa, T.A., Nosè, M., Purgato, M., Omori, I. M., Trespidi, C., & Barbui, C. (2012). Duloxetine versus other anti-depressive agents for depression. Cochrane Database of Systematic Reviews, 10, CD006533. https://doi.org/10.1002/14651858.CD006533.pub2
   PubMedGoogle Scholar
• Conway, K.P., Compton, W., Stinson, F.S., & Grant, B.F. (2006). Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: Results from the national epidemiologic survey on alcohol and related conditions. Journal of Clinical Psychiatry, 67(02), 247–257. https://doi.org/10.4088/JCP.v67n0211
   PubMedGoogle Scholar
• Dobson, K.S., & Mohammadkhani, P. (2007). Psychometric characteristics of beck depression inventory-II in patients with major depressive disorder. Journal of Rehabilitation, 8(2), 80–86.
   Google Scholar
• Elkashef, A., Vocci, F., Hanson, G., White, J., Wickes, W., & Tiihonen, J. (2008). Pharmacotherapy of methamphetamine addiction: An update. Substance Abuse, 29(3), 31–49. https://doi.org/10.1080/08897070802218554
   PubMed Web of Science ®Google Scholar
• Franken, I. H. A., Hendriks, V. M., & Van den Brink, W. (2002). Initial validation of two opiate craving questionnaires: The obsessive compulsive drug use scale (OCDUS) and the desires for drug questionnaire (DDQ). Addictive Behaviors, 27(5), 675–685. https://doi.org/10.1016/S0306-4603(01)00201-5
   PubMed Web of Science ®Google Scholar
• Glasner-Edwards, S., Marinelli-Casey, P., Hillhouse, M., Ang, A., Mooney, L. J., & Rawson, R. (2009). Depression among methamphetamine users: Association with outcomes from the methamphetamine treatment project at 3-year follow-up. Journal of Nervous & Mental Disease, 197(4), 225–231. https://doi.org/10.1097/NMD.0b013e31819db6fe
   PubMed Web of Science ®Google Scholar
• Glasner-Edwards, S., Mooney, L.J., Marinelli-Casey, P., Hillhouse, M., Ang, A., Rawson, R., & Methamphetamine Treatment Project Corporate Authors. (2007). Anxiety disorders among methamphetamine-dependent adults: Association with post-treatment functioning. American Journal on Addictions, 19(5), 385–390. https://doi.org/10.1111/j.1521-0391.2010.00061.x
   Google Scholar
• Gold, M., Redmond, D.E., & Kleber, H. (1978). Clonidine blocks acute opiate-withdrawal symptoms. The Lancet, 312(8090), 599–602. https://doi.org/10.1016/S0140-6736(78)92823-4
   Google Scholar
• Hellem, T.L. (2016). A review of methamphetamine dependence and withdrawal treatment: A focus on anxiety outcomes. Journal of Substance Abuse Treatment, 71, 16–22. https://doi.org/10.1016/j.jsat.2016.08.011
   PubMed Web of Science ®Google Scholar
• Iudicello, J.E., Woods, S.P., Vigil, O., Scott, J.C., Cherner, M., Heaton, R.K., Hampton Atkinson, J., Grant, I., & HIV Neurobehavioral Research Ce, T. (2010). Longer term improvement in neurocognitive functioning and affective distress among methamphetamine users who achieve stable abstinence. Journal of Clinical and Experimental Neuropsychology, 32(7), 704–718. https://doi.org/10.1080/13803390903512637
   PubMed Web of Science ®Google Scholar
• Kelly, M.A., Pavlicova, M., Glass, A., Mariani, J. J., Bisaga, A., Sullivan, M. A., Nunes, E. V., & Levin, F. R. (2014). Do withdrawal-like symptoms mediate increased marijuana smoking in individuals treated with venlafaxine-XR? Drug and Alcohol Dependence, 144, 42–46. https://doi.org/10.1016/j.drugalcdep.2014.06.040
   PubMed Web of Science ®Google Scholar
• Marshall, B.D., & Werb, D. (2010). Health outcomes associated with methamphetamine use among young people: A systematic review. Addiction, 105(6), 991–1002. https://doi.org/10.1111/j.1360-0443.2010.02932.x
   PubMed Web of Science ®Google Scholar
• McDowell, D.M., Levin, F.R., Seracini, A.M., & Nunes, E.V. (2000). Venlafaxine treatment of cocaine abusers with depressive disorders. American Journal of Drug and Alcohol Abuse, 26(1), 25–31. https://doi.org/10.1081/ADA-100100588
   PubMed Web of Science ®Google Scholar
• McGregor, C., Srisurapanont, M., Jittiwutikarn, J., Laobhripatr, S., Wongtan, T., & White, J.M. (2005). The nature, time course and severity of methamphetamine withdrawal. Addiction, 100(9), 1320–1329. https://doi.org/10.1111/j.1360-0443.2005.01160.x
   PubMed Web of Science ®Google Scholar
• Mohammadi, F. (2010). Event-related potentials (ERP) in patients dependent on heroin, crack inducer craving when exposed to visual images before and after therapy, coping skills training, cognitive- behavioral, clinical psychology master’s thesis Tehran University, Faculty of Psychology and Educational Sciences.
   Google Scholar
• Richelson, E. (1996). Synaptic effects of antidepressants. Journal of Clinical Psychopharmacology, 16, 1S–7S. https://doi.org/10.1097/00004714-199606002-00001
   PubMed Web of Science ®Google Scholar
• Rose, M.E., & Grant, J.E. (2008). Pharmacotherapy for methamphetamine dependence: A review of the pathophysiology of methamphetamine addiction and the theoretical basis and efficacy of pharmacotherapeutic interventions. Annals of Clinical Psychiatry, 20(3), 145–155. https://doi.org/10.1080/10401230802177656
   PubMed Web of Science ®Google Scholar
• Sadock, B., Sadock, V., & Ruiz, P. (2015). Kaplan & Sadock’s synopsis of psychiatry : Behavioral sciences/clinical psychiatry. Wolters Kluwer.
   Google Scholar
• Shariat, S. V., & Elahi, A. (2010). Symptoms and course of psychosis after methamphetamine abuse: One-year follow-up of a case. Primary Care Companion to the Journal of Clinical Psychiatry, 12, 5. https://doi.org/10.4088/PCC.10l00959gry
   Google Scholar
• Srisurapanont, M., Ali, R., Marsden, J., Sunga, A., Wada, K., & Monteiro, M. (2003). Psychotic symptoms in methamphetamine psychotic in-patients. The International Journal of Neuropsychopharmacology, 6(4), 347–352. https://doi.org/10.1017/S1461145703003675
   PubMed Web of Science ®Google Scholar
• Srisurapanont, M., Jarusuraisin, N., & Jittiwutikan, J. (1993). Amphetamine withdrawal: I. Reliability, validity and factor structure of a measure. Australian & New Zealand Journal of Psychiatry, 33(1), 89‐93. https://doi.org/10.1046/j.1440-1614.1999.00517.x
   Google Scholar
• Sulaiman, A.H., Said, M.A., Habil, M.H., Rashid, R., Siddiq, A., Guan, N.C., Midin, M., Jaafar, N. R. N., Sidi, H., & Das, S. (2014). The risk and associated factors of methamphetamine psychosis in methamphetamine-dependent patients in Malaysia. Comprehensive Psychiatry, 55, S89–94. https://doi.org/10.1016/j.comppsych.2013.01.003
   PubMed Web of Science ®Google Scholar
• United Nations Office on Drugs and Crime Vienna. (2012). World drug report. United Nations, New York, NY.
   Google Scholar
• Vearrier, D., Greenberg, M.I., Miller, S.N., Okaneku, J.T., & Haggerty, D.A. (2012). Methamphetamine: History, pathophysiology, adverse health effects, current trends, and hazards associated with the clandestine manufacture of methamphetamine. Disease-A-Month, 58(2), 38–89. https://doi.org/10.1016/j.disamonth.2011.09.004
   PubMed Web of Science ®Google Scholar
• Zhang, J., Su, H., Tao, J., Xie, Y., Sun, Y., Li, L., Zhang, X. Y., Hu, Z., & He, J. (2015). Relationship of impulsivity and depression during early methamphetamine withdrawal in Han Chinese population. Addictive Behaviors, 43, 7–10. https://doi.org/10.1016/j.addbeh.2014.10.032
   PubMed Web of Science ®Google Scholar
• Zorick, T., Nestor, L., Miotto, K., Sugar, C., Hellemann, G., Scanlon, G., Rawson, R., & London, E. D. (2010). Withdrawal symptoms in abstinent methamphetamine-dependent subjects. Addiction, 105(10), 1809–1818. https://doi.org/10.1111/j.1360-0443.2010.03066.x
   PubMed Web of Science ®Google Scholar